MENU
MIRM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Mirum Pharmaceuticals (MIRM) Ownership - Who owns Mirum Pharmaceuticals?
Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases... Show more
Profile
Industry
N/A
Address
950 Tower Lane
Phone
+1 650 667-4085
Employees
264
Web
https://www.mirumpharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.95B
P/E Ratio
N/A
Total Cash
280.32M
Projected Growth
N/A
Total Debt
317.76M
Revenue
336.89M
Risk (Beta)
1.02
Dividend Yield
N/A
Total Cash/Share
5.67
Total Debt/Equity
N/A
Revenue/Share
7.09 USD as % of share price
Fundamentals
MIRM
Capitalization
1.95B
P/E Ratio
N/A
Risk (Beta)
1.02
Dividend Yield
N/A
Total Cash
280M
Total Cash/Share
5.67
Total Debt
318M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
7.09%
Revenue
337M
ROE
N/A
Book Value
226M
P/B Ratio
8.64
Cash Flow
N/A
Earnings
-1.85
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
3.10
Current Revenue Per Employee
308739.12
Dividends Per Share - Security
N/A
EBITDA
-48.97M
Float
N/A
Float - Current
N/A
Gross Income Margin
77.09
Revenue To Assets
-13.35
Shares Held By Institutions
3.54B
Shares Outstanding - Current
49.5M
Total Liabilities
445M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-4.244
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company. which focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
950 Tower Lane
Phone
+1 650 667-4085
Employees
264
Web
https://www.mirumpharma.com